MD Anderson Cancer Center / University of Texas — Houston, Texas

MD Anderson Cancer Center / University of Texas is a clinical research site located in Houston, Texas, United States 77030-4095.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center / University of Texas has participated in 28 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Acute Promyelocytic Leukemia.

Sponsors: Seagen Inc., Karyopharm Therapeutics Inc.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center / University of Texas?

MD Anderson Cancer Center / University of Texas has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center / University of Texas conducted?

MD Anderson Cancer Center / University of Texas has 28 clinical trials on record. Their work covers Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Acute Promyelocytic Leukemia.

Is MD Anderson Cancer Center / University of Texas accredited by Crixeo Health?

Yes — MD Anderson Cancer Center / University of Texas holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about MD Anderson Cancer Center / University of Texas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.